Cargando…

Measuring Radiation Toxicity Using Circulating Cell-Free DNA in Prostate Cancer Patients

BACKGROUND: After radiation therapy (RT), circulating plasma cell-free DNA (cfDNA) released in response to RT damage to tissue can be measured within hours. We examined for a correlation between cfDNA measured during the first week of therapy and early and late gastrointestinal (GI) and genitourinar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lockney, Natalie A., Henderson, Randal H., Swarts, Steven G., Zhang, Zhenhuan, Zhang, Bingrong, Li, Jennifer, Zlotecki, Robert A., Morris, Christopher G., Casey-Sawicki, Katherine A., Okunieff, Paul G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Particle Therapy Co-operative Group 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8768895/ https://www.ncbi.nlm.nih.gov/pubmed/35127973 http://dx.doi.org/10.14338/IJPT-D-21-00008

Ejemplares similares

Circulating Cell-Free DNA Correlates with Body Integral Dose and Radiation Modality in Prostate Cancer
por: Lockney, Natalie A., et al.
Publicado: (2020)

Radiation‐induced tumor immunity in patients with non‐small cell lung cancer
por: Lockney, Natalie A., et al.
Publicado: (2019)

Intraoperative radiation therapy for early-stage breast cancer: a single-institution experience
por: Giap, Fantine, et al.
Publicado: (2022)

Radiation Therapy for Advanced-Stage Hodgkin Lymphoma
por: Lockney, Natalie A., et al.
Publicado: (2020)

Mitochondrial DNA and Functional Investigations into the Radiosensitivity of Four Mouse Strains
por: Zhang, Steven B., et al.
Publicado: (2014)

Concomitant Radiation Recall Dermatitis and Organizing Pneumonia following Breast Radiotherapy: A Case Report
por: Liu, I-Chia, et al.
Publicado: (2020)

Normal tissue toxicity after small field hypofractionated stereotactic body radiation
por: Milano, Michael T, et al.
Publicado: (2008)

Triptolide mitigates radiation-induced pneumonitis via inhibition of alveolar macrophages and related inflammatory molecules
por: Chen, Chun, et al.
Publicado: (2017)

Does Race Influence Health-related Quality of Life and Toxicity Following Proton Therapy for Prostate Cancer?
por: Bryant, Curtis, et al.
Publicado: (2016)

Transition Pattern and Mechanism of B-lymphocyte Precursors in Regenerated Mouse Bone Marrow after Subtotal Body Irradiation
por: Han, Deping, et al.
Publicado: (2012)

Stereotactic body radiation therapy for oligoprogression of metastatic disease from gastrointestinal cancers: A novel approach to extend chemotherapy efficacy
por: Wray, Justin, et al.
Publicado: (2017)

The significance of circulating tumor cells in prostate cancer patients undergoing adjuvant or salvage radiation therapy
por: Lowes, L E, et al.
Publicado: (2015)

Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: Results of two prospective trials
por: Henderson, Randal H., et al.
Publicado: (2013)

Stereotactic body radiation therapy for the treatment of oligoprogression on androgen receptor targeted therapy in castration-resistant prostate cancer
por: Nguyen, Thu-Cuc, et al.
Publicado: (2018)

PIK3CA mutation is associated with increased local failure in lung stereotactic body radiation therapy (SBRT)
por: Lockney, Natalie A., et al.
Publicado: (2017)

Evaluation of cytokine expression and circulating immune cell subsets as potential parameters of acute radiation toxicity in prostate cancer patients
por: Stanojković, Tatjana P., et al.
Publicado: (2020)

Comparison of three different methods for the detection of circulating tumor cells in mice with lung metastasis
por: Xu, Weifeng, et al.
Publicado: (2017)

Patient-reported genitourinary toxicity for long-term prostate cancer survivors treated with radiation therapy
por: Olsson, C E, et al.
Publicado: (2013)

Patient-reported sexual toxicity after radiation therapy in long-term prostate cancer survivors
por: Olsson, C E, et al.
Publicado: (2015)

Markers of Toxicity and Response to Radiation Therapy in Patients With Prostate Cancer
por: Nasser, Nicola J., et al.
Publicado: (2020)

Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: A Report on 3-Year Toxicity
por: Paydar, Ima, et al.
Publicado: (2017)

Psychometric properties of a prostate cancer radiation late toxicity questionnaire
por: Rodrigues, George, et al.
Publicado: (2007)

Survey of Radiation Oncologists to Assess Interest and Potential Use of a Genetic Test Predicting Susceptibility for the Development of Toxicities After Prostate Cancer Radiation Therapy
por: Collado, Kayla, et al.
Publicado: (2020)

Treatment-related toxicity using prostate bed versus prostate bed and pelvic lymph node radiation therapy following radical prostatectomy: A national population-based study
por: Sujenthiran, Arunan, et al.
Publicado: (2023)

New Primary Malignancy Masquerading as Metastatic Prostate Adenocarcinoma
por: Szwed, Ellen A., et al.
Publicado: (2015)

Insurance Approval for Definitive Proton Therapy for Prostate Cancer
por: Mendenhall, William M., et al.
Publicado: (2021)

Effect of Large Prostate Volume on Efficacy and Toxicity of Moderately Hypofractionated Radiation Therapy in Patients With Prostate Cancer
por: Natesan, Divya, et al.
Publicado: (2021)

Toxicity and Outcomes of Moderately Hypofractionated Radiation for Prostate Cancer With Seminal Vesicle Involvement
por: Acklin-Wehnert, Scarlett, et al.
Publicado: (2023)

Reduction of Decoy Receptor 3 Enhances TRAIL-Mediated Apoptosis in Pancreatic Cancer
por: Wang, Wei, et al.
Publicado: (2013)

Circulating microRNAs predict biochemical recurrence in prostate cancer patients
por: Selth, L A, et al.
Publicado: (2013)

Does the radiation approach affect acute toxicity in prostate cancer patients? A comparison of four radiation techniques
por: Poźniak-Balicka, Róża, et al.
Publicado: (2020)

Efficacy and toxicity of external-beam radiation therapy for localised prostate cancer: a network meta-analysis
por: Zhu, Z, et al.
Publicado: (2014)

Relationship between Circulating Lipids and Cytokines in Metastatic Castration-Resistant Prostate Cancer
por: Lin, Hui-Ming, et al.
Publicado: (2021)

An amino acid-based oral rehydration solution (AA-ORS) enhanced intestinal epithelial proliferation in mice exposed to radiation
por: Yin, Liangjie, et al.
Publicado: (2016)

Hypofractionated Stereotactic Radiotherapy for Non-breast or Prostate Cancer Oligometastases: A Tail of Survival Beyond 10 Years
por: Aujla, Khush S., et al.
Publicado: (2019)

Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression
por: Kil, Whoon Jong, et al.
Publicado: (2013)

Toxicity of Tomotherapy-Based Simultaneous Integrated Boost in Whole-Pelvis Radiation for Prostate Cancer
por: You, Sei Hwan, et al.
Publicado: (2015)

A Comparison between Patient- and Physician-Reported Late Radiation Toxicity in Long-Term Prostate Cancer Survivors
por: Nuijens, Anna C., et al.
Publicado: (2022)

Collaborative Response of the Host and Symbiotic Lignocellulytic System to Non-Lethal Toxic Stress in Coptotermes formosanus Skiraki
por: Zeng, Wenhui, et al.
Publicado: (2021)

Predictive Factors Increasing the Risk of Radiation Toxicity in Patients with Early Breast Cancer
por: Abdeltawab, Asmaa A, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tub3drji5gm9mmad9kpoiul74d